Stoke Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.About STOK
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.
CEOIan Frederick Smith
CEOIan Frederick Smith
Employees128
Employees128
HeadquartersBedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded2014
Founded2014
Employees128
Employees128
STOK Key Statistics
Market cap1.65B
Market cap1.65B
Price-Earnings ratio37.51
Price-Earnings ratio37.51
Dividend yield—
Dividend yield—
Average volume930.48K
Average volume930.48K
High today$32.06
High today$32.06
Low today$28.10
Low today$28.10
Open price$31.53
Open price$31.53
Volume1.34M
Volume1.34M
52 Week high$38.69
52 Week high$38.69
52 Week low$5.35
52 Week low$5.35
STOK News
TipRanks 4d
Stoke Therapeutics Advances Phase 3 Study for Dravet Syndrome TreatmentStoke Therapeutics ((STOK)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% of...
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.